Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-15

Clinical Trial Update: Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ketorolac infiltration as premedication to reduce post-endodontic pain in irreversible pulpitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac (Ketorolac tromethamine)

Snippet

Sponsor: Azad University of Medical Sciences | Conditions: Irreversible Pulpitis | Phase 2 | Status: COMPLETED